Sol-Gel Technologies (SLGL) Receivables (2019 - 2026)
Sol-Gel Technologies' Receivables came in at $713,000 for Q2 2026, down 92.9% from $10.04 million a year earlier and down 33.2% from the prior quarter.
Powered by 
Analysis
Sol-Gel Technologies (SLGL) Receivables (2019 - 2026) Analysis & Trends
At the end of FY2025, Sol-Gel Technologies' Receivables was $1.97 million, down 45.3% from FY2024.
- Receivables carries a five-year compound annual growth rate of -1.8% (FY2020 to FY2025).
- Going back by year, Receivables was $3.6 million in FY2024 (+853.6%), $377,000 in FY2023 (-95.2%), $7.86 million in FY2022 (+6.2%) and $7.4 million in FY2021 (+243.8%).
- The Q2 2026 figure represents the lowest quarterly Receivables since Q4 2023.
- Year-over-year, Receivables has declined for three consecutive quarters, with growth averaging 156.5% over the last seven quarters.
- The fastest year-over-year change in Receivables over five years came in Q2 2022 (growth of 964.4%), and the weakest in Q4 2023 (a decline of 95.2%).
- Business Quant data shows SLGL's Receivables at $1.07 million (Q1 2026), $1.97 million (Q4 2025) and $9.85 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.13 Bn |
| 10 | Sol-Gel Technologies | 193.50 Mn | 47.91 Mn | - | 713,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 713,000.00 |
| Mar 31, 2026 | 1.07 Mn |
| Dec 31, 2025 | 1.97 Mn |
| Sep 30, 2025 | 9.85 Mn |
| Jun 30, 2025 | 10.04 Mn |
| Mar 31, 2025 | 3.88 Mn |
| Dec 31, 2024 | 3.60 Mn |
| Sep 30, 2024 | 7.02 Mn |
| Jun 30, 2024 | 6.06 Mn |
| Mar 31, 2024 | 869,000.00 |
| Dec 31, 2023 | 377,000.00 |
| Jun 30, 2023 | 2.43 Mn |
| Mar 31, 2023 | 5.81 Mn |
| Dec 31, 2022 | 7.86 Mn |
| Sep 30, 2022 | 10.78 Mn |
| Jun 30, 2022 | 10.18 Mn |
| Mar 31, 2022 | 9.66 Mn |
| Dec 31, 2021 | 7.40 Mn |
| Sep 30, 2021 | 1.39 Mn |
| Jun 30, 2021 | 956,000.00 |
API Access
Sol-Gel Technologies Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=SLGL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "SLGL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=SLGL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();